Target intelligence / Profile preview

Tumor Tissue via Localized Beta Radiation

Molecular classification
Radiation Therapy, Cellular Target
01

Overview

Localized beta radiation therapy targets tumor tissue by delivering beta-emitting radionuclides directly to or near the tumor site. The emitted beta particles cause DNA damage, leading to cell cycle arrest and apoptosis. Selectivity is achieved through carrier molecules that bind to tumor-specific receptors. A key advantage is the cross-fire effect, but potential off-target toxicity due to the long particle range is a major limitation.

Other names
Localized Beta Radiation TherapyBeta Radiation for Tumor TreatmentRadionuclide Therapy for CancerTargeted Beta Therapy
02

Mechanism of action

Localized beta radiation therapy delivers beta-emitting radionuclides to or near the tumor site. Beta particles cause ionization and excitation in cellular components, particularly DNA, leading to direct and indirect DNA damage, cell cycle arrest, and apoptosis. The cross-fire effect irradiates multiple adjacent cancer cells.

03

Biological functions

ApoptosisCell cycle arrestDNA damageTumor cell deathInhibition of cell proliferation
04

Disease associations

CancerMetastatic CancerNeuroendocrine TumorsBone Metastases
05

Safety considerations

Off-target toxicity to surrounding healthy tissuesCollateral damage due to long-range emission of beta particlesRadiation-induced side effects (e.g., myelosuppression, nephrotoxicity)Efficacy may be reduced in hypoxic tumorsPotential for treatment resistanceSmaller lesions (< particle range) cause energy to escape normal tissues
06

Interacting drugs

Beta-emitting radionuclides (e.g., Lutetium-177, Yttrium-90)

4 more in the full profile.

07

Biomarkers

Tumor receptor expression (e.g., somatostatin receptors for PRRT)Tumor size and locationExtent of disease (localized vs. metastatic)Oxygenation status of the tumor (hypoxia may reduce efficacy)Radionuclide uptake in tumor tissue

Beyond the preview

Go deeper on Tumor Tissue via Localized Beta Radiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Tissue via Localized Beta Radiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call